Korean J Fertil Steril Search

CLOSE


Clin Exp Reprod Med > Epub ahead of print
Han: Endometrial microbiome in reproductive failure: The possibility of metagenomic analysis

Abstract

With the advent of metagenomics and 16S ribosomal RNA sequencing, growing attention has been dedicated to the endometrial microbiome. Research involving a relatively large cohort of healthy female participants has reported Lactobacillus dominance (LD) in the endometrial microbiome. Multiple studies have also shown that the loss of LD and/or increased microbial diversity within the endometrium are associated with reproductive failure. This phenomenon may stem from the loss of the immunomodulatory effects of Lactobacillus and the rise of proinflammatory responses triggered by pathogenic proliferation. Recent research has employed personalized antibiotic therapy followed by probiotic supplementation, tailored to the endometrial microbial composition of women with repeated implantation failure. The findings suggest that metagenomic analysis of the endometrial microbiome could be a valuable tool in addressing reproductive failure.

Introduction

Implantation is a process that requires close interactions between the embryo and the endometrium. Failure of implantation can be attributed to embryonic or maternal factors. Preimplantation genetic testing for aneuploidy (PGT-A) has enabled in vitro fertilization and embryo transfer (IVF-ET) to achieve clinical pregnancy rates (CPRs) of over 60% following an ET cycle [1]. However, even after addressing various maternal factors, including anatomical abnormalities of the uterus and systemic immunologic and thrombogenic issues, the rate of repeated implantation failure (RIF) with the transfer of euploid embryos remains approximately 5% [2].
It is widely acknowledged that certain bacterial infections can establish an inflammatory environment in the female genital tract, potentially leading to infertility and adverse obstetric outcomes [3,4]. However, until recently, our understanding of the microbiomes in the female genital tract was primarily limited to a few pathogens detectable with conventional culture techniques or polymerase chain reaction. The Human Genome Project revealed that approximately 9% of the total body microbiome is derived from the female genital tract, with many species remaining undetectable through conventional culture methods [5]. Recent advances in metagenomic studies, particularly those employing 16S ribosomal RNA (rRNA) sequencing, have facilitated a deeper exploration of the female genital tract microbiota and its association with various reproductive diseases.
In this review, we aim to summarize the association between the female genital tract microbiome and reproductive failure (RF), focusing on the endometrial microbiome.

Vaginal microbiome and reproductive health

Over a century ago, Dr. Albert Doderlein reported the predominance of Lactobacillus in the vaginal microbial community. Since then, extensive research has shown that Lactobacillus dominance (LD) in the vagina promotes reproductive health [6]. Conversely, dysbiosis of the vaginal microbiota, characterized by the loss of LD and an increase in α-diversity (that is, a greater variety and evenness of species), has been associated with a number of gynecological conditions, including bacterial vaginosis, sexually transmitted infections, cervical cancer, and endometriosis [7-9]. Additionally, this state has been linked to multiple adverse pregnancy outcomes, such as preterm birth, preterm premature rupture of membranes, and premature cervical dilatation [10-12].
Recently, research has focused on the relationship between the vaginal microbiome and miscarriage. A prospective study that analyzed the vaginal microbiome starting at 5 weeks of gestation found that first-trimester miscarriage was associated with a decreased abundance of Lactobacilli and increased α-diversity [13]. Additional research has indicated that a reduction in LD within the vaginal microbial community is linked to euploid miscarriage and elevated levels of proinflammatory cytokines [14,15].
During IVF, vaginal samples can be readily collected and analyzed using metagenomic methods. One study revealed a positive correlation between LD in the vaginal microbiome and the CPR in women undergoing IVF-ET [16]. Furthermore, a recent study observed that women with RIF exhibited higher vaginal microbial diversity compared to women who achieved clinical pregnancy in their first frozen ET cycle [17].
The initial discovery of the microbiome in the uterine endometrium, which was based on 58 samples from hysterectomy procedures performed for benign disease [18], dispelled the misconception that the uterus was sterile. This finding paved the way for subsequent studies focused on the endometrial microbiome. With the advent of next-generation sequencing (NGS) of bacterial 16S rRNA, research has shifted from the vaginal microbiome to the endometrial microbiome, particularly regarding its implications for reproductive health and implantation [19].

Endometrial microbiome and reproductive failure

The initial characterization of the uterine endometrial microbiome from the hysterectomy sample provided irrefutable evidence of its independent existence, as it eliminated the possibility of contamination from the vagina [18]. Subsequent research using hysterectomy and simultaneous vaginal samples, along with a large-scale study involving samples from 110 women at six sites within the female reproductive tract, identified a similar microbial composition (including LD) between the vagina and endometrium. However, this research also noted a gradient of microbial diversity from the lower to the upper reproductive tract [20,21].
A study published in 2000 found that a higher live birth rate was associated with a positive culture for H2O2-producing Lactobacillus in 91 women undergoing IVF [22]. Subsequent research using 16S rRNA sequencing revealed a relationship between the abundance of Lactobacilli in the endometrial microbiome and more favorable pregnancy rates in women undergoing ET [23-25], although some findings did not reach statistical significance [26]. In contrast, another study observed no significant differences in implantation and miscarriage rates between groups with non-LD and LD endometrial microbiota compositions, even though a higher prevalence of LD was noted in fertile controls [27]. Furthermore, the study reported seven pregnancies in the non-LD group without any intervention.
The endometrium is regulated by sex hormones. A notable study from 2016 assessed the differences in endometrial microbiome composition between the pre-receptive phase (2 days after the luteinizing hormone [LH] surge) and the receptive phase (7 days after the LH surge) using 44 paired endometrial samples. The study found no differences in microbial composition within the same woman between the pre-receptive and receptive phases [24]. Another study also reported a stable endometrium, with regard to LD, throughout the menstrual cycle [26]. However, a different study employing meta-transcriptomics, as opposed to metagenomics with 16S rRNA, identified a significant difference in the microbiome between the early follicular phase (days 6–8 of the menstrual cycle) and the mid-luteal phase (7–9 days post-LH surge) [28]. Furthermore, other researchers have observed similar cyclic changes in the composition of the vaginal microbiome [29,30]. Interestingly, all studies that showed a significantly positive correlation between LD of the endometrial microbiome and favorable CPR in IVF cycles involved endometrial sampling at the time of ET or during the preceding mid-luteal phase—essentially, within the window of implantation [22-25]. In contrast, studies that did not suggest this correlation did not acquire samples during these times [26,27]. These findings suggest potential variations in the microbial composition of the endometrium throughout the menstrual cycle.
Similar to a study on the vaginal microbiome [31], the endometrial microbiome was analyzed using 16S rRNA sequencing to compare the microbial composition between individuals with missed abortion and those with induced abortion at the time of abortion [32,33]. The endometrial microbial composition of the missed abortion group was distinct from that of the induced abortion group. Additional research has examined the endometrial microbiome in women with a history of recurrent pregnancy loss (RPL), contrasting it with that of fertile controls. These studies were all conducted during the mid-luteal phase and revealed differences in the endometrial microbial composition between women with RPL and fertile control participants, although the details were not consistent across studies. Some research identified specific pathological microbial elevation in women with RPL [34], while others reported variations in the abundance of Lactobacillus spp. [35,36] or a loss of LD in this population [37].
RIF, RPL, and unexplained infertility are collectively classified as a single disease entity known as RF. Numerous studies have suggested the existence of certain common etiologies across these conditions [38,39]. Among investigations of the endometrial microbiome, several studies have explored RPL while also incorporating RIF or infertility [23,37]. These studies are listed in Table 1. In contrast, some research has focused exclusively on RIF. One such study compared the endometrial microbiome of 28 women with RIF to that of 18 infertile women undergoing their first IVF-ET cycle. The findings indicated higher β-diversity and the presence of Burkholderia spp. solely in the RIF group [40]. Another study observed increased α-diversity in the endometrial microbiome of 117 women with RIF compared to 17 healthy controls [41]. Subsequent research has explored the potential for treating RIF with antibiotics. One study demonstrated that antibiotic therapy improved the CPR and ongoing pregnancy rate in 125 women with RIF who had pathogenic bacteria in their endometrium [42]. Another study involving 131 patients with RIF, who were analyzed using EMMA—a commercial service for endometrial microbiota analysis employing NGS of microbial 16S rRNA—reported a relatively high cumulative CPR of 64.5% within two additional ETs after a personalized regimen of antibiotics followed by probiotics [43].

Potential mechanism

Despite a general consensus regarding the association between the endometrial microbiome and RF, the underlying mechanism remains elusive. Research has uncovered two phenomena contributing to this association. The first involves LD in the endometrial microbiome. The protective role of Lactobacillus spp. in preventing pathogen colonization is well-documented [44,45], with lactic acid production by Lactobacilli being the primary mechanism. While the healthy vaginal cavity is acidic due in part to LD, the endometrial cavity typically is not, even when Lactobacilli are plentiful [21]. Recent serial studies of systemic lupus erythematosus (SLE) have uncovered various immunomodulatory effects of Lactobacilli. Administration of probiotics containing certain Lactobacillus spp. was associated with increased regulatory T cells and forkhead box P3 (Foxp3) expression and decreased interleukin 6 levels in a mouse model of SLE [46]. Additionally, treatment with Lactobacilli in macrophages and dendritic cells from patients with SLE resulted in anti-inflammatory shifts in cytokine secretion [47,48].
The second potential phenomenon linking the endometrial microbiome to RF is microbial diversity, including pathogens. Research indicates that Lactobacilli do not trigger inflammation or cause cell death in endometrial cells [49]. Furthermore, an increase in pathogens within the endometrium has been associated with RIF and RPL [34,50]. Pathogenic infections can induce proinflammatory mediators in the endometrium, leading to a disruption of the immune milieu that is crucial for successful implantation and the maintenance of pregnancy. However, cases of chronic endometritis may occur without evidence of specific pathogenic infection, presenting instead as increased α-diversity, the loss of LD, and the heightened expression of proinflammatory and apoptotic genes [50-52].

Limitations of current research

To date, numerous studies have identified associations between the endometrial microbiome and RF, including infertility, RPL, and RIF. Notably, some research has highlighted differences in the endometrial microbial composition between fertile and infertile women, as well as among women with varying pregnancy outcomes, such as missed abortion versus induced abortion and RIF versus successful pregnancy following a first attempt at IVF-ET. These findings suggest that deviations in the endometrial microbiome from that of healthy fertile controls may influence RF. However, without definitive evidence of causation, it remains difficult to ascertain whether changes in the endometrial microbiome directly contribute to RF. Moreover, inconsistencies in the timing of endometrial microbial sampling across studies hinder the ability to draw consistent conclusions. Only a few studies have compared pregnancy outcomes by transferring exclusively euploid embryos via PGT-A to minimize bias from embryonic factors. Consequently, to establish a causal link between the endometrial microbiome and fertility outcomes, and to elucidate the mechanisms involved, it is essential to standardize the timing and methodology of endometrial sampling, ensure the quality of transferred embryos to mitigate the influence of embryonic factors, and conduct longitudinal follow-ups of reproductive outcomes to clarify the cause-and-effect relationship.
Recently, several studies explored the potential effectiveness of treatments targeting abnormal endometrial microbiomes in cases of RIF and RPL. However, the value of these treatments remains unclear, and the evidence supporting their efficacy is limited. Moreover, the optimal treatment approach has yet to be established. While most research has focused on eradicating pathogens using antibiotics, some studies have concentrated on restoring a healthy LD environment by administering Lactobacillus spp. following antibiotic treatment. The effectiveness of oral Lactobacillus supplementation for re-establishing LD in the female genital tract microbiome is still a topic of debate [53]. Recent research has pivoted towards the vaginal administration of Lactobacillus [43,54]. Additionally, vaginal microbiome transplantation has been attempted [55]. Further research is necessary to ascertain whether interventions targeting the endometrial microbiome can improve reproductive outcomes in populations affected by RF.
Sampling the endometrial microbiome is more invasive and susceptible to contamination than obtaining samples from the vaginal microbiome. Additionally, the data derived from the endometrial microbiome cannot yet be deemed superior to those from the vaginal microbiome. These factors present challenges to researchers and clinicians in accurately characterizing the endometrial microbiome and clarifying its role in reproductive health.

Conclusion

The advent of metagenomics and 16S rRNA sequencing has provided growing evidence supporting the role of the endometrial microbiome in RF. However, further research is needed to fully comprehend its implications and to develop potential therapeutic interventions. Addressing challenges associated with study design, sample collection, and data interpretation is critical to advance our knowledge in this area.

Conflict of interest

No potential conflict of interest relevant to this article was reported.

Table 1.
Endometrial microbiome composition in women with reproductive failure
Study No. and type of patients Sampling time Findings
Shu et al. (2022) [32] 17 Missed abortions vs. 12 induced abortions Just before D&C Higher β-diversity in the missed abortion group
Wang et al. (2023) [33] 38 Early missed abortions vs. 18 induced abortions Just before D&C Significant difference in EM and vaginal microbiome between two groups
Shi et al. (2022) [34] 67 RPL Mid-luteal phase prior to pregnancy More Ureaplasma spp. in the abortion or preterm birth group
Masucci et al. (2023) [35] 40 RPL vs. 7 fertile controls Mid-luteal phase Less Lactobacillus acidophilus and the presence of L. inners only in the RPL group
Peuranpaa et al. (2022) [36] 47 RPL vs. 39 fertile controls Mid-luteal phase Less L. crispatus and more Gardnerella vaginalis in the RPL group
Vomstein et al. (2022) [37] 20 RPL and 20 RIF vs. 10 fertile controls Follicular, periovulatory, and luteal phase Decreased α-diversity during periovulatory and luteal phase only in controls
Kitaya et al. (2019) [40] 28 RIF vs. 18 infertile women in 1st attempt of ET Mid-luteal phase Presence of Burkholderia spp. only in a portion of RIF group (25%)
Ichiyama et al. (2021) [41] 145 RIF vs. 21 fertile controls Early & mid-luteal phase Higher α-diversity in the RIF group but no difference in the proportion of Lactobacillus between the two groups
Zou et al. (2023) [42] 141 RIF women Mid-luteal phase Most women with RIF (88.7%) had pathogenic bacteria in EM
Iwami et al. (2023) [43] Among 195 RIF, 131 tested with ‘EMMA’a) and treated vs. 64 not tested Mid-luteal phase In the following ET, higher CPR and ongoing pregnancy rates in the tested and treated group
Moore et al. (2000) [22] 91 Infertile women undergoing IVF, culture methodb) Just before ET Higher LBR associated with isolated H2O2-producing Lactobacillus
Moreno et al. (2022) [23] 342 Infertile women undergoing IVF Mid-luteal phase Higher LBR associated with Lactobacillus
Moreno et al. (2016) [24] 35 Infertile women undergoing IVF Periovulatory vs. mid-luteal phase Different EM microbiomes in periovulatory and mid-luteal phases, lower implantation rate and higher LBR in the LD group
Diaz-Martinez et al. (2021) [25] 48 Infertile women undergoing IVF Luteal phase Lactobacillus spp. more abundant in pregnant women
Kyono et al. (2018) [26] 102 Infertile women Various phases, mainly follicular LD in 38% of IVF patients, 78.9% in non-IVF patients, and 85.9% in controls, similar LBR in LD and non-LD groups
Hashimoto et al. (2019) [27] 99 Infertile women undergoing IVF Mock transfer (no other description) Similar CPR, IR, and MR in dysbiotic and eubiotic endometrium group

D&C, dilatation and curettage; EM, endometrial; RPL, women with a history of recurrent pregnancy loss; RIF, women with a history of repeated implantation failure; ET, embryo transfer; CPR, clinical pregnancy rate; IVF, in vitro fertilization; LBR, live birth rate; LD, Lactobacillus dominant; IR, implantation rate; MR, miscarriage rate.

a)‘EMMA’, a commercial service for endometrial microbiota analysis; b)All studies employed next-generation sequencing with 16S rRNA sequencing except one study marked as ‘Culture method.’

References

1. Capalbo A, Rienzi L, Cimadomo D, Maggiulli R, Elliott T, Wright G, et al. Correlation between standard blastocyst morphology, euploidy and implantation: an observational study in two centers involving 956 screened blastocysts. Hum Reprod 2014;29:1173-81.
crossref pmid
2. Pirtea P, Scott RT Jr, de Ziegler D, Ayoubi JM. Recurrent implantation failure: how common is it? Curr Opin Obstet Gynecol 2021;33:207-12.
crossref pmid
3. Gravett MG, Nelson HP, DeRouen T, Critchlow C, Eschenbach DA, Holmes KK. Independent associations of bacterial vaginosis and Chlamydia trachomatis infection with adverse pregnancy outcome. JAMA 1986;256:1899-903.
crossref pmid
4. Giakoumelou S, Wheelhouse N, Cuschieri K, Entrican G, Howie SE, Horne AW. The role of infection in miscarriage. Hum Reprod Update 2016;22:116-33.
crossref pmid pmc
5. Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature 2012;486:207-14.
crossref pmid pmc pdf
6. Kroon SJ, Ravel J, Huston WM. Cervicovaginal microbiota, women’s health, and reproductive outcomes. Fertil Steril 2018;110:327-36.
crossref pmid
7. Ventolini G, Vieira-Baptista P, De Seta F, Verstraelen H, Lonnee-Hoffmann R, Lev-Sagie A. The vaginal microbiome: IV. the role of vaginal microbiome in reproduction and in gynecologic cancers. J Low Genit Tract Dis 2022;26:93-8.
crossref pmid pmc
8. Salliss ME, Farland LV, Mahnert ND, Herbst-Kralovetz MM. The role of gut and genital microbiota and the estrobolome in endometriosis, infertility and chronic pelvic pain. Hum Reprod Update 2021;28:92-131.
crossref pmid pdf
9. Kwon MS, Lee HK. Host and microbiome interplay shapes the vaginal microenvironment. Front Immunol 2022;13:919728.
crossref pmid pmc
10. Bayar E, Bennett PR, Chan D, Sykes L, MacIntyre DA. The pregnancy microbiome and preterm birth. Semin Immunopathol 2020;42:487-99.
crossref pmid pmc pdf
11. Bennett PR, Brown RG, MacIntyre DA. Vaginal microbiome in preterm rupture of membranes. Obstet Gynecol Clin North Am 2020;47:503-21.
crossref pmid
12. Brown RG, Chan D, Terzidou V, Lee YS, Smith A, Marchesi JR, et al. Prospective observational study of vaginal microbiota pre- and post-rescue cervical cerclage. BJOG 2019;126:916-25.
crossref pmid pmc pdf
13. Al-Memar M, Bobdiwala S, Fourie H, Mannino R, Lee YS, Smith A, et al. The association between vaginal bacterial composition and miscarriage: a nested case-control study. BJOG 2020;127:264-74.
crossref pmid pmc pdf
14. Grewal K, Lee YS, Smith A, Brosens JJ, Bourne T, Al-Memar M, et al. Chromosomally normal miscarriage is associated with vaginal dysbiosis and local inflammation. BMC Med 2022;20:38.
crossref pmid pmc pdf
15. Xu L, Huang L, Lian C, Xue H, Lu Y, Chen X, et al. Vaginal microbiota diversity of patients with embryonic miscarriage by using 16S rDNA high-throughput sequencing. Int J Genomics 2020;2020:1764959.
crossref pmid pmc pdf
16. Hyman RW, Herndon CN, Jiang H, Palm C, Fukushima M, Bernstein D, et al. The dynamics of the vaginal microbiome during infertility therapy with in vitro fertilization-embryo transfer. J Assist Reprod Genet 2012;29:105-15.
crossref pmid pmc pdf
17. Fu M, Zhang X, Liang Y, Lin S, Qian W, Fan S. Alterations in vaginal microbiota and associated metabolome in women with recurrent implantation failure. mBio 2020;11:e03242-19.
crossref pmid pmc pdf
18. Mitchell CM, Haick A, Nkwopara E, Garcia R, Rendi M, Agnew K, et al. Colonization of the upper genital tract by vaginal bacterial species in nonpregnant women. Am J Obstet Gynecol 2015;212:611.
crossref pmid pmc
19. Toson B, Simon C, Moreno I. The endometrial microbiome and its impact on human conception. Int J Mol Sci 2022;23:485.
crossref pmid pmc
20. Miles SM, Hardy BL, Merrell DS. Investigation of the microbiota of the reproductive tract in women undergoing a total hysterectomy and bilateral salpingo-oopherectomy. Fertil Steril 2017;107:813-20.
crossref pmid
21. Chen C, Song X, Wei W, Zhong H, Dai J, Lan Z, et al. The microbiota continuum along the female reproductive tract and its relation to uterine-related diseases. Nat Commun 2017;8:875.
crossref pmid pmc pdf
22. Moore DE, Soules MR, Klein NA, Fujimoto VY, Agnew KJ, Eschenbach DA. Bacteria in the transfer catheter tip influence the live-birth rate after in vitro fertilization. Fertil Steril 2000;74:1118-24.
crossref pmid
23. Moreno I, Garcia-Grau I, Perez-Villaroya D, Gonzalez-Monfort M, Bahceci M, Barrionuevo MJ, et al. Endometrial microbiota composition is associated with reproductive outcome in infertile patients. Microbiome 2022;10:1.
crossref pmid pmc pdf
24. Moreno I, Codoner FM, Vilella F, Valbuena D, Martinez-Blanch JF, Jimenez-Almazan J, et al. Evidence that the endometrial microbiota has an effect on implantation success or failure. Am J Obstet Gynecol 2016;215:684-703.
crossref pmid
25. Diaz-Martinez MD, Bernabeu A, Lledo B, Carratala-Munuera C, Quesada JA, Lozano FM, et al. Impact of the vaginal and endometrial microbiome pattern on assisted reproduction outcomes. J Clin Med 2021;10:4063.
crossref pmid pmc
26. Kyono K, Hashimoto T, Nagai Y, Sakuraba Y. Analysis of endometrial microbiota by 16S ribosomal RNA gene sequencing among infertile patients: a single-center pilot study. Reprod Med Biol 2018;17:297-306.
crossref pmid pmc
27. Hashimoto T, Kyono K. Does dysbiotic endometrium affect blastocyst implantation in IVF patients? J Assist Reprod Genet 2019;36:2471-9.
crossref pmid pmc pdf
28. Sola-Leyva A, Andres-Leon E, Molina NM, Terron-Camero LC, Plaza-Diaz J, Saez-Lara MJ, et al. Mapping the entire functionally active endometrial microbiota. Hum Reprod 2021;36:1021-31.
crossref pmid pdf
29. Yamamoto T, Zhou X, Williams CJ, Hochwalt A, Forney LJ. Bacterial populations in the vaginas of healthy adolescent women. J Pediatr Adolesc Gynecol 2009;22:11-8.
crossref
30. Ravel J, Gajer P, Abdo Z, Schneider GM, Koenig SS, McCulle SL, et al. Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci U S A 2011;108 Suppl 1:4680-7.
crossref pmid pmc
31. Sun D, Zhao X, Pan Q, Li F, Gao B, Zhang A, et al. The association between vaginal microbiota disorders and early missed abortion: a prospective study. Acta Obstet Gynecol Scand 2022;101:960-71.
crossref pmid pmc pdf
32. Shu J, Lin S, Wu Y, Zhu J, Gong D, Zou X, et al. A potential role for the uterine microbiome in missed abortions. J Biol Regul Homeost Agents 2022;36:1055-63.

33. Wang L, Chen J, He L, Liu H, Liu Y, Luan Z, et al. Association between the vaginal and uterine microbiota and the risk of early embryonic arrest. Front Microbiol 2023;14:1137869.
crossref pmid pmc
34. Shi Y, Yamada H, Sasagawa Y, Tanimura K, Deguchi M. Uterine endometrium microbiota and pregnancy outcome in women with recurrent pregnancy loss. J Reprod Immunol 2022;152:103653.
crossref
35. Masucci L, D’Ippolito S, De Maio F, Quaranta G, Mazzarella R, Bianco DM, et al. Celiac disease predisposition and genital tract microbiota in women affected by recurrent pregnancy loss. Nutrients 2023;15:221.
crossref pmid pmc
36. Peuranpaa P, Holster T, Saqib S, Kalliala I, Tiitinen A, Salonen A, et al. Female reproductive tract microbiota and recurrent pregnancy loss: a nested case-control study. Reprod Biomed Online 2022;45:1021-31.
crossref
37. Vomstein K, Reider S, Bottcher B, Watschinger C, Kyvelidou C, Tilg H, et al. Uterine microbiota plasticity during the menstrual cycle: differences between healthy controls and patients with recurrent miscarriage or implantation failure. J Reprod Immunol 2022;151:103634.
crossref
38. Han AR, Han JW, Lee SK. Inherited thrombophilia and anticoagulant therapy for women with reproductive failure. Am J Reprod Immunol 2021;85:e13378.
crossref pdf
39. Makrigiannakis A, Petsas G, Toth B, Relakis K, Jeschke U. Recent advances in understanding immunology of reproductive failure. J Reprod Immunol 2011;90:96-104.
crossref pmid
40. Kitaya K, Nagai Y, Arai W, Sakuraba Y, Ishikawa T. Characterization of microbiota in endometrial fluid and vaginal secretions in infertile women with repeated implantation failure. Mediators Inflamm 2019;2019:4893437.
crossref pmid pmc pdf
41. Ichiyama T, Kuroda K, Nagai Y, Urushiyama D, Ohno M, Yamaguchi T, et al. Analysis of vaginal and endometrial microbiota communities in infertile women with a history of repeated implantation failure. Reprod Med Biol 2021;20:334-44.
crossref pmid pmc pdf
42. Zou Y, Liu X, Chen P, Wang Y, Li W, Huang R. The endometrial microbiota profile influenced pregnancy outcomes in patients with repeated implantation failure: a retrospective study. J Reprod Immunol 2023;155:103782.
crossref pmid
43. Iwami N, Kawamata M, Ozawa N, Yamamoto T, Watanabe E, Mizuuchi M, et al. Therapeutic intervention based on gene sequencing analysis of microbial 16S ribosomal RNA of the intrauterine microbiome improves pregnancy outcomes in IVF patients: a prospective cohort study. J Assist Reprod Genet 2023;40:125-35.
crossref pmid pdf
44. Witkin SS, Linhares IM. Why do lactobacilli dominate the human vaginal microbiota? BJOG 2017;124:606-11.
crossref pmid pdf
45. Boris S, Barbes C. Role played by lactobacilli in controlling the population of vaginal pathogens. Microbes Infect 2000;2:543-6.
crossref pmid
46. Khorasani S, Mahmoudi M, Kalantari MR, Lavi Arab F, Esmaeili SA, Mardani F, et al. Amelioration of regulatory T cells by Lactobacillus delbrueckii and Lactobacillus rhamnosus in pristane-induced lupus mice model. J Cell Physiol 2019;234:9778-86.
crossref pmid pdf
47. Esmaeili SA, Mahmoudi M, Rezaieyazdi Z, Sahebari M, Tabasi N, Sahebkar A, et al. Generation of tolerogenic dendritic cells using Lactobacillus rhamnosus and Lactobacillus delbrueckii as tolerogenic probiotics. J Cell Biochem 2018;119:7865-72.
crossref pmid pdf
48. Javanmardi Z, Mahmoudi M, Rafatpanah H, Rezaieyazdi Z, Shapouri-Moghaddam A, Ahmadi P, et al. Tolerogenic probiotics Lactobacillus delbrueckii and Lactobacillus rhamnosus promote anti-inflammatory profile of macrophages-derived monocytes of newly diagnosed patients with systemic lupus erythematosus. Cell Biochem Funct 2024;42:e3981.
crossref pmid
49. Shiroda M, Manning SD. Lactobacillus strains vary in their ability to interact with human endometrial stromal cells. PLoS One 2020;15:e0238993.
crossref pmid pmc
50. Chen P, Chen P, Guo Y, Fang C, Li T. Interaction between chronic endometritis caused endometrial microbiota disorder and endometrial immune environment change in recurrent implantation failure. Front Immunol 2021;12:748447.
crossref pmid pmc
51. Cicinelli E, Matteo M, Tinelli R, Pinto V, Marinaccio M, Indraccolo U, et al. Chronic endometritis due to common bacteria is prevalent in women with recurrent miscarriage as confirmed by improved pregnancy outcome after antibiotic treatment. Reprod Sci 2014;21:640-7.
crossref pmid pmc pdf
52. Liu Y, Ko EY, Wong KK, Chen X, Cheung WC, Law TS, et al. Endometrial microbiota in infertile women with and without chronic endometritis as diagnosed using a quantitative and reference range-based method. Fertil Steril 2019;112:707-17.
crossref pmid
53. van de Wijgert J, Verwijs MC. Lactobacilli-containing vaginal probiotics to cure or prevent bacterial or fungal vaginal dysbiosis: a systematic review and recommendations for future trial designs. BJOG 2020;127:287-99.
crossref pmid pdf
54. Cohen CR, Wierzbicki MR, French AL, Morris S, Newmann S, Reno H, et al. Randomized trial of lactin-V to prevent recurrence of bacterial vaginosis. N Engl J Med 2020;382:1906-15.
crossref pmid pmc
55. Lev-Sagie A, Goldman-Wohl D, Cohen Y, Dori-Bachash M, Leshem A, Mor U, et al. Vaginal microbiome transplantation in women with intractable bacterial vaginosis. Nat Med 2019;25:1500-4.
crossref pmid pdf
TOOLS
Share :
Facebook Twitter Linked In Google+ Line it
METRICS Graph View
  • 0 Crossref
  •   Scopus
  • 331 View
  • 7 Download
Related articles in Clin Exp Reprod Med


ABOUT
ARTICLE CATEGORY

Browse all articles >

BROWSE ARTICLES
AUTHOR INFORMATION
Editorial Office
Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital
82 Gumi-ro 173, Bundang-gu, Seongnam 13620, Korea
Tel: +82-31-787-7254    CP: +82-10-9072-3154    E-mail: blasto@snubh.org                

Copyright © 2025 by Korean Society for Reproductive Medicine.

Developed in M2PI

Close layer
prev next